Glenmark to set up first manufacturing plant in USIllustrative image – not actual.

Glenmark Pharmaceuticals plans to set up its first manufacturing plant in the US. The company aims to invest over Rs 500 crore on the project.


The proposed manufacturing facility at Monroe, North Carolina, will house three units to produce oral solids, injectables and topicals. The company will first begin work on an oral solid unit and thereafter set up manufacturing units for injectables and topicals. Production is likely to begin by the end of the current fiscal.


The plant will cater only to the US market and is the company's first manufacturing facility in North America. At present, Glenmark has 14 plants across four countries - India, Brazil, Argentina and Czech Republic.


 

← All latest storiesBack to top →